News

 

At AseBio, we follow the latest news in the biotechnology sector and pass the highlights on to you. You can use the search engine to find news articles we’ve written, contributed by our members or from other stakeholders in the sector. And they are also organised into categories to help you find the topics you’re interested in easily.

Search engine
Imagen de una estructura de adn
Key Considerations for Cell and Gene Therapy Commercialization in Non-Orphan Indications
Healthcare · Access to innovation · Drug discovery
There are two important challenges for companies aiming to develop CGTs in mainstream indications.
Oryzon_AseBio
Oryzon selected as Associated Partner in the first Important Project of Common European Interest (IPCEI) in the health sector (Med4Cure project)
Healthcare · Access to innovation · Drug discovery · Rare diseases · Innovative drugs · Personalized medicine · Financing
Commission has approved up to €1 billion of State aid by six Member States: Belgium, France,…
Partners - Oryzon Genomics
Banderas de la Unión Europea ondeando frente a un edificio
Four AseBio partners will participate in the first IPCEI in the health sector that will mobilize €1 billion in grants
Healthcare · Access to innovation · Financing
The Major Project of Common European Interest 'Med4Cure' will enable member states to support a…
Foto de una prueba de Thalassemia
BCN HEALTH publishes a study estimating the cost of thalassaemia care across the world
Healthcare · Rare diseases
BCN HEALTH desarrolló un modelo de costes aplicable a nivel mundial para la atención de la…
Partners - BCN Health
Debate sobre la colaboración y la transferencia biotecnológica en investigación biomédica
Collaboration, efficient management of intellectual property and creation of spin-offs, vital for technology transfer and a thriving innovation ecosystem
Healthcare · Access to innovation
AseBio has organized, within the framework of the XVII Annual Conference of Biomedical Research…
Foto de un ojo y un colirio y/o gotas
Miramoon Pharma Receives Orphan Drug Designation for MP-004
Healthcare · Access to innovation · Rare diseases · Innovative drugs
Orphan Drug Designation is a special status granted by the FDA to drugs that are intended to treat…
Partners - Miramoon Pharma
Foto de cuatro manos
Atlas Molecular Pharma successfully completes phase one in humans of its treatment for Congenital Erythropoietic Porphyria Erythropoietica Congenita
Healthcare · Access to innovation · Drug discovery · Rare diseases · Innovative drugs · Personalized medicine
The final results of ATL-001, the biotech company's lead candidate, have shown that it is able to…
Partners - Inveready
Banner del galicia biodays
Galicia Biodays, the European Atlantic Area meeting point for life sciences and biotechnology
International
The reference forum of the biotechnology and life sciences industry in the European Atlantic Area…
Partners - BIOGA
Foto del CEO de Celavista frente a las oficinas
Aircure®Tech, a technology that will change the way we correct excess CO2
Healthcare · Agrifood · Agriculture · Digitalization
Since 2023, the company has been certified as an Innovative SME.